![Jeff Baxter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Baxter
Chief Executive Officer at
VBI Vaccines (Delaware), Inc.
Profile
Mr. Jeffrey R. Baxter is a President, Chief Executive Officer & Director at VBI Vaccines, Inc., an Independent Non-Executive Director at Chromadex Corp., a President, Chief Executive Officer & Director at VBI Vaccines (Delaware), Inc. and a President, Chief Executive Officer & Director at Variation Biotechnologies (US), Inc. He is on the Board of Directors at VBI Vaccines, Inc., Chromadex Corp., VBI Vaccines (Delaware), Inc. and Variation Biotechnologies (US), Inc. Mr. Baxter was previously employed as a SVP-Finance, Operations, Research & Development by GlaxoSmithKline Plc, a Principal by British American Tobacco plc, a Managing Partner by The Column Group LLC, and a Principal by Unilever Plc. He received his undergraduate degree from Thames Valley University.
Jeff Baxter active positions
| Companies | Position | Start |
|---|---|---|
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | President | - |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Chief Executive Officer | 30/06/2014 |
Former positions of Jeff Baxter
| Companies | Position | End |
|---|---|---|
| VBI VACCINES INC. | Chief Executive Officer | 02/01/2025 |
| NIAGEN BIOSCIENCE, INC. | Director/Board Member | 03/04/2022 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Chief Investment Officer | 27/02/2009 |
| GSK PLC | Corporate Officer/Principal | 30/06/2006 |
| UNILEVER PLC | Corporate Officer/Principal | - |
Training of Jeff Baxter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
56
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
British American Tobacco plc
 British American Tobacco plc TobaccoConsumer Non-Durables Manufactures and supplies tobacco products | Consumer Non-Durables |
Unilever Plc
 Unilever Plc Household/Personal CareConsumer Non-Durables Provides fast moving consumer goods | Consumer Non-Durables |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
University of West London
 University of West London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Jeff Baxter
